University of Dundee

Latest News for 11/2018

November 2018

  • 05 Nov 2018

    The success of a University of Dundee collaboration that has attracted almost £60 million of investment, helped develop dozens of drugs for clinical use and won the prestigious Queen’s Anniversary Award will be celebrated this week. Scientists, politicians and representatives of some of the world’s biggest pharmaceutical companies will come together to mark the 20th anniversary of the University of Dundee’s Division of Signal Transduction Therapy (DSTT).

May 2018

  • Dario Alessi being presented with the Langston Award by Shalini Padmanabhan, Terina Martinez and Marco Baptista
    07 May 2018

    The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded MRC PPU Director Dario Alessi the 2018 MJFF Langston Award for “service and dedication to our shared goals of advancing Parkinson's understanding and therapeutic development”. For further information see here. 

April 2018

March 2018

October 2017

  • 10 Oct 2017

    Researchers in the laboratory of Professor Alessio Ciulli have designed a small molecule that tricks a particular E3 ubiquitin ligase protein to destroy another of its kind. E3 ligases act like ‘molecular assassins’ in cells as they naturally tag unwanted proteins for cellular degradation. There are believed to be over 600 E3 ligases in the human cell and many are involved in human diseases, providing many attractive targets for drug discovery.

August 2016

  • 01 Aug 2016

    Researchers led by the University of Dundee’s Professor Dario Alessi have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson’s disease. The team believes this research, which is published in Biochemical Journal, could help pave the way for future development of a clinical test that could facilitate evaluation of drugs to target this form of the condition.

January 2016

  • 28 Jan 2016

    International Consortium Identifies and Validates Cellular Role of Priority Parkinson’s Disease Drug Target, LRRK2 Kinase   An international public-private consortium of researchers brought together by the University of Dundee and led by The Michael J. Fox Foundation for Parkinson’s Research has identified and validated for the first time the cellular role of a primary Parkinson’s disease drug target.  

February 2014

  • 04 Feb 2014

    The Academy of Medical Sciences announced this week that Professor Dario Alessi FRS FRSE FMedSci will deliver the Raymond and Beverly Sackler Distinguished Lecture in the Medical Sciences on 2 July 2014, as part of the annual Fellows Admission Day. Professor Alessi, Director of the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee, was elected as a Fellow of the Academy in 2012.

July 2013

May 2012

  • 22 May 2012

    Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson’s disease. The findings have helped scientists understand how genetic mutations in a gene called PINK1 lead to Parkinson’s in patients as young as 8 years old - which could eventually lead to new ways to diagnose and treat the condition.

Pages